This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Mar;59(3):257-259.

doi: 10.1080/0284186X.2019.1695063. Epub 2019 Nov 22.

Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels

A Sibille¹, M Henket¹, J L Corhay¹, R Louis¹, B Duysinx¹

Affiliations

PMID: 31755328
DOI: 10.1080/0284186X.2019.1695063

Free article

Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels

A Sibille et al. Acta Oncol. 2020 Mar.

Free article

. 2020 Mar;59(3):257-259.

doi: 10.1080/0284186X.2019.1695063. Epub 2019 Nov 22.

Authors

A Sibille¹, M Henket¹, J L Corhay¹, R Louis¹, B Duysinx¹

Affiliation

¹ CHU de Liège-Hôpital du Sart Tilman, Liège, Belgium.

PMID: 31755328
DOI: 10.1080/0284186X.2019.1695063

No abstract available

PubMed Disclaimer

Similar articles

There and back again: An immunotherapy tale.
Guo Y, Krupnick AS. Guo Y, et al. J Thorac Cardiovasc Surg. 2018 Apr;155(4):1771-1774. doi: 10.1016/j.jtcvs.2017.11.102. Epub 2017 Dec 23. J Thorac Cardiovasc Surg. 2018. PMID: 29409610 No abstract available.
KEYNOTE-024: Unlocking a pathway to lung cancer cure?
Rusch VW, Chaft J, Hellmann M. Rusch VW, et al. J Thorac Cardiovasc Surg. 2018 Apr;155(4):1777-1780. doi: 10.1016/j.jtcvs.2017.10.155. Epub 2017 Dec 23. J Thorac Cardiovasc Surg. 2018. PMID: 29395215 No abstract available.
[Immuno-checkpoint inhibitor resistance and strategy in lung cancer].
Jiang WR, Fang LP, Chang N, Zhang J. Jiang WR, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jul 12;43(7):603-606. doi: 10.3760/cma.j.cn112147-20200312-00319. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32629564 Review. Chinese.
Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report.
Gelsomino F, Di Federico A, Filippini DM, Dall'Olio FG, Lamberti G, Sperandi F, Balacchi C, Brocchi S, Ardizzoni A. Gelsomino F, et al. Clin Lung Cancer. 2020 Mar;21(2):e45-e48. doi: 10.1016/j.cllc.2019.11.011. Epub 2019 Nov 20. Clin Lung Cancer. 2020. PMID: 31902695 No abstract available.
Role of immune-checkpoint inhibitors in lung cancer.
Jain P, Jain C, Velcheti V. Jain P, et al. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817750075. doi: 10.1177/1753465817750075. Ther Adv Respir Dis. 2018. PMID: 29385894 Free PMC article. Review.

See all similar articles

Cited by

Eosinophilia in cancer and its regulation by sex hormones.
Artham S, Chang CY, McDonnell DP. Artham S, et al. Trends Endocrinol Metab. 2023 Jan;34(1):5-20. doi: 10.1016/j.tem.2022.11.002. Epub 2022 Nov 26. Trends Endocrinol Metab. 2023. PMID: 36443206 Free PMC article. Review.
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach.
Fameli A, Nardone V, Shekarkar Azgomi M, Bianco G, Gandolfo C, Oliva BM, Monoriti M, Saladino RE, Falzea A, Romeo C, Calandruccio ND, Azzarello D, Giannicola R, Pirtoli L, Giordano A, Tassone P, Tagliaferri P, Cusi MG, Mutti L, Botta C, Correale P. Fameli A, et al. Front Oncol. 2022 Sep 14;12:911579. doi: 10.3389/fonc.2022.911579. eCollection 2022. Front Oncol. 2022. PMID: 36185285 Free PMC article.
Immunity and Breast Cancer: Focus on Eosinophils.
Poncin A, Onesti CE, Josse C, Boulet D, Thiry J, Bours V, Jerusalem G. Poncin A, et al. Biomedicines. 2021 Aug 26;9(9):1087. doi: 10.3390/biomedicines9091087. Biomedicines. 2021. PMID: 34572273 Free PMC article. Review.
White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer.
Sibille A, Henket M, Corhay JL, Alfieri R, Louis R, Duysinx B. Sibille A, et al. Lung. 2021 Oct;199(5):549-557. doi: 10.1007/s00408-021-00474-2. Epub 2021 Sep 13. Lung. 2021. PMID: 34518898 Free PMC article.
Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse.
Onesti CE, Josse C, Boulet D, Thiry J, Beaumecker B, Bours V, Jerusalem G. Onesti CE, et al. Oncoimmunology. 2020 May 13;9(1):1761176. doi: 10.1080/2162402X.2020.1761176. Oncoimmunology. 2020. PMID: 32923121 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ORBi (University of Liege)
- Taylor & Francis
Medical
- Genetic Alliance
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program